189 related articles for article (PubMed ID: 37468189)
1. Omega-3 Fatty Acid Biomarkers and Incident Atrial Fibrillation.
Qian F; Tintle N; Jensen PN; Lemaitre RN; Imamura F; Feldreich TR; Nomura SO; Guan W; Laguzzi F; Kim E; Virtanen JK; Steur M; Bork CS; Hirakawa Y; O'Donoghue ML; Sala-Vila A; Ardisson Korat AV; Sun Q; Rimm EB; Psaty BM; Heckbert SR; Forouhi NG; Wareham NJ; Marklund M; Risérus U; Lind L; Ärnlöv J; Garg P; Tsai MY; Pankow J; Misialek JR; Gigante B; Leander K; Pester JA; Albert CM; Kavousi M; Ikram A; Voortman T; Schmidt EB; Ninomiya T; Morrow DA; Bayés-Genís A; O'Keefe JH; Ong KL; Wu JHY; Mozaffarian D; Harris WS; Siscovick DS;
J Am Coll Cardiol; 2023 Jul; 82(4):336-349. PubMed ID: 37468189
[TBL] [Abstract][Full Text] [Related]
2. n-3 Fatty Acid Biomarkers and Incident Type 2 Diabetes: An Individual Participant-Level Pooling Project of 20 Prospective Cohort Studies.
Qian F; Ardisson Korat AV; Imamura F; Marklund M; Tintle N; Virtanen JK; Zhou X; Bassett JK; Lai H; Hirakawa Y; Chien KL; Wood AC; Lankinen M; Murphy RA; Samieri C; Pertiwi K; de Mello VD; Guan W; Forouhi NG; Wareham N; Hu ICFB; Riserus U; Lind L; Harris WS; Shadyab AH; Robinson JG; Steffen LM; Hodge A; Giles GG; Ninomiya T; Uusitupa M; Tuomilehto J; Lindström J; Laakso M; Siscovick DS; Helmer C; Geleijnse JM; Wu JHY; Fretts A; Lemaitre RN; Micha R; Mozaffarian D; Sun Q;
Diabetes Care; 2021 May; 44(5):1133-1142. PubMed ID: 33658295
[TBL] [Abstract][Full Text] [Related]
3. n-6 fatty acid biomarkers and incident atrial fibrillation: an individual participant-level pooled analysis of 11 international prospective studies.
Garg PK; Guan W; Nomura S; Weir NL; Tintle N; Virtanen JK; Hirakawa Y; Qian F; Sun Q; Rimm E; Lemaitre RN; Jensen PN; Heckbert SR; Imamura F; Steur M; Leander K; Laguzzi F; Voortman T; Ninomiya T; Mozaffarian D; Harris WS; Siscovick DS; Tsai MY;
Am J Clin Nutr; 2023 Nov; 118(5):921-929. PubMed ID: 37769813
[TBL] [Abstract][Full Text] [Related]
4. Dietary ω-3 fatty acids and the incidence of atrial fibrillation in the Million Veteran Program.
Guardino ET; Li Y; Nguyen XM; Wilson PWF; Gaziano JM; Cho K; Benjamin EJ; Djoussé L
Am J Clin Nutr; 2023 Aug; 118(2):406-411. PubMed ID: 37353210
[TBL] [Abstract][Full Text] [Related]
5. Association Between Omega-3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESA.
Kapoor K; Alfaddagh A; Al Rifai M; Bhatt DL; Budoff MJ; Nasir K; Miller M; Welty FK; McEvoy JW; Dardari Z; Shapiro MD; Blumenthal RS; Tsai MY; Blaha MJ
J Am Heart Assoc; 2021 Jun; 10(11):e021431. PubMed ID: 34041918
[TBL] [Abstract][Full Text] [Related]
6. ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies.
Del Gobbo LC; Imamura F; Aslibekyan S; Marklund M; Virtanen JK; Wennberg M; Yakoob MY; Chiuve SE; Dela Cruz L; Frazier-Wood AC; Fretts AM; Guallar E; Matsumoto C; Prem K; Tanaka T; Wu JH; Zhou X; Helmer C; Ingelsson E; Yuan JM; Barberger-Gateau P; Campos H; Chaves PH; Djoussé L; Giles GG; Gómez-Aracena J; Hodge AM; Hu FB; Jansson JH; Johansson I; Khaw KT; Koh WP; Lemaitre RN; Lind L; Luben RN; Rimm EB; Risérus U; Samieri C; Franks PW; Siscovick DS; Stampfer M; Steffen LM; Steffen BT; Tsai MY; van Dam RM; Voutilainen S; Willett WC; Woodward M; Mozaffarian D;
JAMA Intern Med; 2016 Aug; 176(8):1155-66. PubMed ID: 27357102
[TBL] [Abstract][Full Text] [Related]
7. Fish, fish-derived n-3 fatty acids, and risk of incident atrial fibrillation in the Atherosclerosis Risk in Communities (ARIC) study.
Gronroos NN; Chamberlain AM; Folsom AR; Soliman EZ; Agarwal SK; Nettleton JA; Alonso A
PLoS One; 2012; 7(5):e36686. PubMed ID: 22570739
[TBL] [Abstract][Full Text] [Related]
8. Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study.
Wu JH; Lemaitre RN; King IB; Song X; Sacks FM; Rimm EB; Heckbert SR; Siscovick DS; Mozaffarian D
Circulation; 2012 Mar; 125(9):1084-93. PubMed ID: 22282329
[TBL] [Abstract][Full Text] [Related]
9. Changes in eicosapentaenoic acid and docosahexaenoic acid and risk of cardiovascular events and atrial fibrillation: A secondary analysis of the OMEMI trial.
Myhre PL; Kalstad AA; Tveit SH; Laake K; Schmidt EB; Smith P; Nilsen DWT; Tveit A; Solheim S; Arnesen H; Seljeflot I
J Intern Med; 2022 May; 291(5):637-647. PubMed ID: 34982486
[TBL] [Abstract][Full Text] [Related]
10. Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial.
Albert CM; Cook NR; Pester J; Moorthy MV; Ridge C; Danik JS; Gencer B; Siddiqi HK; Ng C; Gibson H; Mora S; Buring JE; Manson JE
JAMA; 2021 Mar; 325(11):1061-1073. PubMed ID: 33724323
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acids in adipose tissue and risk of atrial fibrillation.
Rix TA; Dinesen P; Lundbye-Christensen S; Joensen AM; Riahi S; Overvad K; Schmidt EB
Eur J Clin Invest; 2022 Jan; 52(1):e13649. PubMed ID: 34233016
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality.
Jiang H; Wang L; Wang D; Yan N; Li C; Wu M; Wang F; Mi B; Chen F; Jia W; Liu X; Lv J; Liu Y; Lin J; Ma L
Clin Nutr; 2022 Aug; 41(8):1798-1807. PubMed ID: 35830775
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.
Balk EM; Adams GP; Langberg V; Halladay C; Chung M; Lin L; Robertson S; Yip A; Steele D; Smith BT; Lau J; Lichtenstein AH; Trikalinos TA
Evid Rep Technol Assess (Full Rep); 2016 Aug; (223):1-1252. PubMed ID: 30307737
[TBL] [Abstract][Full Text] [Related]
14. Circulating long-chain ω-3 fatty acids and incidence of congestive heart failure in older adults: the cardiovascular health study: a cohort study.
Mozaffarian D; Lemaitre RN; King IB; Song X; Spiegelman D; Sacks FM; Rimm EB; Siscovick DS
Ann Intern Med; 2011 Aug; 155(3):160-70. PubMed ID: 21810709
[TBL] [Abstract][Full Text] [Related]
15. A U-shaped association between consumption of marine n-3 fatty acids and development of atrial fibrillation/atrial flutter-a Danish cohort study.
Rix TA; Joensen AM; Riahi S; Lundbye-Christensen S; Tjønneland A; Schmidt EB; Overvad K
Europace; 2014 Nov; 16(11):1554-61. PubMed ID: 24574493
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 Fatty Acids and Markers of Thrombosis in Patients with Atrial Fibrillation.
Reiner MF; Bertschi DA; Werlen L; Wiencierz A; Aeschbacher S; Lee P; Rodondi N; Moutzouri E; Bonati L; Reichlin T; Moschovitis G; Rutishauser J; Kühne M; Osswald S; Conen D; Beer JH
Nutrients; 2024 Jan; 16(2):. PubMed ID: 38257071
[TBL] [Abstract][Full Text] [Related]
17. (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?
Mozaffarian D; Wu JH
J Nutr; 2012 Mar; 142(3):614S-625S. PubMed ID: 22279134
[TBL] [Abstract][Full Text] [Related]
18. Intake of total omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid and risk of coronary heart disease in the Spanish EPIC cohort study.
Amiano P; Machón M; Dorronsoro M; Chirlaque MD; Barricarte A; Sánchez MJ; Navarro C; Huerta JM; Molina-Montes E; Sánchez-Cantalejo E; Urtizberea M; Arriola L; Larrañaga N; Ardanaz E; Quirós JR; Moreno-Iribas C; González CA
Nutr Metab Cardiovasc Dis; 2014 Mar; 24(3):321-7. PubMed ID: 24360762
[TBL] [Abstract][Full Text] [Related]
19. Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial.
Wu JH; Marchioli R; Silletta MG; Macchia A; Song X; Siscovick DS; Harris WS; Masson S; Latini R; Albert C; Brown NJ; Lamarra M; Favaloro RR; Mozaffarian D
J Am Heart Assoc; 2013 Oct; 2(5):e000397. PubMed ID: 24145742
[TBL] [Abstract][Full Text] [Related]
20. Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults: a cohort study.
Mozaffarian D; Lemaitre RN; King IB; Song X; Huang H; Sacks FM; Rimm EB; Wang M; Siscovick DS
Ann Intern Med; 2013 Apr; 158(7):515-25. PubMed ID: 23546563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
